Video Experimental Relacionado
Updated: Jun 17, 2026
08:20
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
Published on: October 2, 2018
Flavonoides y síndrome de ovario poliquístico
1Medical College, Guangxi University, Nanning, Guangxi, 530004, China. liuyu@gxu.edu.cn.
Food & function
|February 19, 2026
Resumen
Los flavonoides ofrecen una terapia natural prometedora para el síndrome de ovario poliquístico (SOP), reduciendo la inflamación y mejorando la salud metabólica. Estos compuestos vegetales muestran un potencial para un manejo más seguro del SOP en comparación con los tratamientos convencionales.
Área de la Ciencia:
- Endocrinología
- Ciencia de la Nutrición
- Farmacología
Sus antecedentes:
- El síndrome de ovario poliquístico (SOP) es un trastorno endocrino complejo que afecta la salud reproductiva y metabólica de las mujeres.
- Los tratamientos actuales para el SOP, como los COCP y la metformina, tienen limitaciones y efectos adversos.
- Existe una necesidad crítica de alternativas terapéuticas más seguras y bien toleradas para el manejo del SOP.
Objetivo del estudio:
- Revisar sistemáticamente la evidencia preclínica y clínica sobre la eficacia de los flavonoides en el manejo del SOP.
- Elucidar los mecanismos moleculares subyacentes a los efectos terapéuticos de los flavonoides en el SOP.
- Resumir las mejoras en los parámetros endocrinos y metabólicos en pacientes con SOP tratados con flavonoides.
Principales métodos:
- Revisión sistemática de estudios preclínicos en modelos de SOP.
- Análisis de ensayos clínicos que investigan la suplementación con flavonoides en pacientes con SOP.
- Examen de vías moleculares que incluyen Nrf2, NF-κB, inflamasomas NLRP3 y señalización AMPK.
Principales resultados:
- Los flavonoides mitigan el estrés oxidativo y la inflamación relacionados con el SOP a través de la activación de Nrf2 y la inhibición de NF-κB/NLRP3.
- Los estudios preclínicos muestran que los flavonoides reducen los andrógenos y la insulina séricos, y mejoran la morfología ovárica.
- Los ensayos clínicos demuestran que la quercetina, las isoflavonas de soja y la puerarina mejoran los marcadores endocrinos/metabólicos del SOP y la calidad ovocitaria.
Conclusiones:
- Los flavonoides presentan una estrategia terapéutica viable para el SOP, abordando características patológicas clave.
- Las propiedades antiinflamatorias y antioxidantes de los flavonoides, mediadas por vías de señalización específicas, son cruciales para su eficacia.
- Los flavonoides representan un enfoque natural prometedor para mejorar los síntomas del SOP y los resultados de los pacientes.
Videos de Conceptos Relacionados
02:07Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
01:22Hormonal Regulation of the Menstrual Cycle
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
01:27Ovarian Cycle
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
01:30Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
01:24Disorders of the Female Reproductive System
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...